GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition

Zhou Yang1, Dejun Wu1, Yusheng Chen1

  • 1Department of General Surgery, Shanghai Pudong Hospital, Fudan University Pudong Medical Center , Shanghai , China.

Insights

Grainyhead-like 2 (GRHL2) and ZEB1 suppress colorectal cancer (CRC) progression and metastasis by inhibiting epithelial-mesenchymal transition (EMT). GRHL2 knockdown promotes CRC cell migration, invasion, and metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Colorectal cancer (CRC) progression is linked to epithelial-mesenchymal transition (EMT).
  • Grainyhead-like 2 (GRHL2) has been previously shown to inhibit CRC cell proliferation by targeting ZEB1.

Purpose of the Study:

  • To investigate the role of GRHL2 in promoting CRC progression and metastasis via EMT.
  • To elucidate the relationship between GRHL2 and ZEB1 in regulating CRC cell behavior.

Main Methods:

  • Generation of GRHL2-overexpressing and GRHL2-knockdown CRC cell lines.
  • Analysis of EMT markers (E-cadherin, Vimentin, β-catenin, ZO-1, ZEB1) using qRT-PCR, Western blotting, and immunofluorescence.
  • In vitro assays (Transwell, wound healing) and in vivo mouse tail vein injection model to assess migration, invasion, and metastasis.

Main Results:

  • GRHL2 overexpression induced mesenchymal-epithelial transition (MET) with increased epithelial markers and decreased mesenchymal markers.
  • GRHL2 knockdown promoted EMT, increasing migration, invasion, and metastasis in vitro and in vivo.
  • GRHL2 and ZEB1 expression were inversely correlated; ZEB1 knockdown partially rescued the effects of GRHL2 knockdown.

Conclusions:

  • The GRHL2/ZEB1 axis plays a crucial role in inhibiting CRC progression and metastasis.
  • Suppressing EMT through the GRHL2/ZEB1 pathway represents a potential therapeutic strategy for colorectal cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
Phase Transitions02:31

Phase Transitions

Whether solid, liquid, or gas, a substance's state depends on the order and arrangement of its particles (atoms, molecules, or ions). Particles in the solid pack closely together, generally in a pattern. The particles vibrate about their fixed positions but do not move or squeeze past their neighbors. In liquids, although the particles are closely spaced, they are randomly arranged. The position of the particles are not fixed—that is, they are free to move past their neighbors to...
22.8K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.0K
Properties of Transition Metals02:58

Properties of Transition Metals

Transition metals are defined as those elements that have partially filled d orbitals. As shown in Figure 1, the d-block elements in groups 3–12 are transition elements. The f-block elements, also called inner transition metals (the lanthanides and actinides), also meet this criterion because the d orbital is partially occupied before the f orbitals.
29.7K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K